Healthcare Online Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.

Press releases published on October 30, 2026

Oct. 30, 2026

The Adult Spinal Deformity Market Is Projected to Grow to $3.37 Billion by 2030 with a CAGR of 5.4%

Indeterminate EIN Presswire

Oct. 30, 2026

Avonex Market Report Covers Key Segments, Regional Developments, and Leading Competitors

Indeterminate EIN Presswire

Oct. 30, 2026

The Global Avastin (Bevacizumab) Market is Experiencing a Rapid Growth Phase

Indeterminate EIN Presswire

Oct. 30, 2026

Autoplex Market Forecast to 2030: Size, Growth Rate, Trends, and Analysis

Indeterminate EIN Presswire

Oct. 30, 2026

Recent Market Analysis of Asparlas (calaspargase pegol) by The Business Research Company

Indeterminate EIN Presswire

Oct. 30, 2026

Audenz Market Forecast Report Including Segment Analysis and Strategic Industry Insights

Indeterminate EIN Presswire

Oct. 30, 2026

Atgam Market Trends and Forecast Analysis Indicate Significant Long-Term Growth Potential

Indeterminate EIN Presswire

Oct. 30, 2026

Attenuvax Market Analysis Report Examining Demand Patterns and Competitive Landscape

Indeterminate EIN Presswire

Oct. 30, 2026

Detailed Atryn Market Report Includes Forecasts, Innovations, and Industry Perspectives

Indeterminate EIN Presswire

Oct. 30, 2026

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 30, 2026

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 30, 2026

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 30, 2026

Sienna Completes Acquisition in Ottawa

Indeterminate GlobeNewswire

Oct. 30, 2026

Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

Oct. 30, 2026

NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes

Indeterminate GlobeNewswire

Oct. 30, 2026

Polk County Mosquito Control Reduces Aedes aegypti by Up to 95% with Sterile Insect Farms™ Sterile Male Releases

Indeterminate GlobeNewswire

Oct. 30, 2026

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Indeterminate GlobeNewswire

Oct. 30, 2026

Texas Handicap Parking Placards: HandicapMD Publishes VTR-214 Medical Certification Resource

Indeterminate EIN Presswire

Oct. 30, 2026

Detailed Advanced Melanoma Market Report Includes Forecasts, Innovations, and Industry Insights

Indeterminate EIN Presswire

Oct. 30, 2026

Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)

Indeterminate GlobeNewswire